Moncef Saloui, the former chair of R&D at GlaxoSmithKline, on 15 May was named the chief scientific adviser for Operation Warp Speed at a White House press conference.
By Jon CohenScience's COVID-19 reporting is supported by the Pulitzer Center.When the news broke yesterday that Operation Warp Speed had selected 5 experimental COVID-19 vaccines to fast track through testing and, potentially, mass-scale production, it was news even to some top scientists involved with the White House-led program. “It’s been so chaotic, and it’s not even transparent to those of us who are trying to help out,” says a source linked to Warp Speed who asked not to be named.The New York Times said that, according to “senior officials,” the Trump Administration